Botswana Vaccines Import Market -- HS Code 3002 Trade Data & Price Trend (May 2025)

Botswana Vaccines Import (HS 3002) Key Takeaways

Botswana's vaccines import (HS Code 3002) in May 2025 reveals a high-value, specialized market dominated by veterinary and human medical products, with unit prices ranging from $17 to $244, reflecting differentiated demand. The market is volatile, with unit prices spiking to $143/kg amid supply disruptions from U.S. tariff hikes, while import volume sharply contracted. Supplier concentration is extreme, with top players handling 97.83% of import value, creating efficiency but also supply chain risks. Geographically, the UK leads in high-value shipments (51.99% by value), while South Africa dominates volume (77.20%), highlighting a dual reliance on premium and bulk supply. This analysis is based on cleanly processed customs data from the yTrade database for May 2025.

Botswana Vaccines Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood, vaccines, toxins, and cultures. These products are critical for healthcare, pharmaceuticals, and veterinary industries, driving consistent global demand due to their essential role in disease prevention and treatment. Botswana's vaccines import under this code reflects its reliance on these products for public health and agricultural sustainability.

Current Context and Strategic Position

On 2 April 2025, the U.S. Administration increased the additional duty on all imports from Botswana to 37%, effective 9 April 2025 [Global Trade Alert]. This policy shift could indirectly impact Botswana's vaccines import by altering trade dynamics or supply chain costs. Given the country's dependence on imported vaccines for healthcare and livestock management, monitoring HS Code 3002 trade data is crucial to assess potential disruptions and ensure supply stability. Strategic vigilance is needed to navigate these evolving trade conditions.

Botswana Vaccines Import (HS 3002) Price Trend

Key Observations

Botswana's vaccine imports for May 2025 closed at a total value of $1.42 million USD, with a notable unit price of $143.34 per kilogram. This represents a significant sequential increase in the cost per unit, even as the total import volume for the month contracted sharply.

Price and Volume Dynamics

The overall hs code 3002 value trend for early 2025 was highly volatile, marked by a major surge in March to $3.86 million. This was followed by a sharp decline in April and a partial rebound in May. The extreme fluctuation in unit price—from $42.80/kg in February to over $143/kg in May—strongly suggests market disruption, most likely linked to the U.S. Administration’s April 9th announcement [Global Trade Alert] of a 37% additional duty on all imports from Botswana. This policy shift appears to have abruptly rerouted or constrained supply channels, driving up per-unit costs even as total import weight fell. The Botswana Vaccines Import trend reflects these acute external pressures on procurement and pricing stability.

Botswana Vaccines Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

According to yTrade data, Botswana's import of HS Code 3002 in May 2025 shows a highly specialized market with one product having an extreme unit price. The sub-code for "Toxins, cultures of micro-organisms (excluding yeasts) and similar products; not elsewhere classified" commands over 5,317 USD per unit, which is isolated as an anomaly due to its outlier status. After isolation, the market is led by "Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for veterinary medicine", which accounts for 30.96% of the import value with a unit price of 17.08 USD per unit.

Value-Chain Structure and Grade Analysis

The non-anomalous imports fall into two groups: veterinary preparations and human medical products. Veterinary vaccines dominate in volume and value share. Human medical products include immunological preparations and blood fractions, with unit prices ranging from 117 to 244 USD per unit, indicating higher value-add and specialization. This variation in prices points to a trade in differentiated manufactured goods, not uniform commodities, as products are tailored for specific uses like animal or human health.

Strategic Implication and Pricing Power

For businesses involved in Botswana's HS Code 3002 import, pricing power depends on product specificity. Veterinary items face more competition due to lower prices, while human medical products allow for premium pricing. Strategy should focus on sourcing specialized goods and meeting quality standards, as shown by HS Code 3002 trade data, to navigate this segmented market effectively.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Vaccines Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

In May 2025, Botswana's imports of Vaccines were heavily concentrated, with the United Kingdom dominating by value at 51.99% share but only 1.14% by quantity, indicating a focus on high-grade or premium vaccines. South Africa led in quantity with 77.20% share and frequency at 41.72%, suggesting bulk or standard vaccine shipments. The disparity between value and quantity shares points to South Africa supplying lower-cost variants, while the UK provides higher-value products.

Origin Countries Clusters and Underlying Causes

The origin countries for Botswana's Vaccines imports form distinct clusters. A high-yield cluster includes the United Kingdom, Switzerland, and Germany, where value shares exceed quantity shares, signaling demand for specialized or branded vaccines. A volume cluster is centered on South Africa, with its high quantity share, likely due to proximity and cost-effective bulk supply. A transactional cluster with high frequency, including South Africa, the United States, and Germany, reflects regular, smaller shipments for consistent distribution needs.

Forward Strategy and Supply Chain Implications

Botswana's reliance on South Africa for volume poses a supply chain risk; diversifying sources could reduce dependency and ensure stability. The small share from Uruguay might be influenced by tariff rate quotas noted in January 2025 [BURS], but the impact is minimal. Prioritizing secure imports from high-value partners like the UK is key for maintaining quality in Botswana's Vaccines supply chain.

Table: Botswana Vaccines (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Vaccines (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

In May 2025, the Botswana vaccines import suppliers market is dominated by a small group of high-value, high-frequency players. According to yTrade data, these suppliers handled 97.83% of the total import value and 80.98% of shipment frequency, indicating that most trade involves regular, high-volume transactions. The typical import for vaccines is characterized by large, frequent shipments from key sources.

Strategic Supplier Clusters and Trade Role

The profile of HS code 3002 suppliers shows that the dominant group consists of manufacturers like PHIBRO ANIMAL HEALTH PTY LTD and DIAGNOSTECH PTY LTD, pointing to a direct-to-factory sourcing model. A smaller cluster of low-value, high-frequency suppliers, including ELANCO and IRVINES AFRICA, contributes minimally to value but adds diversity through more frequent, smaller shipments, likely acting as secondary or local distributors.

Sourcing Strategy and Vulnerability

Botswana's heavy reliance on a few high-value suppliers for vaccines imports creates efficiency but also concentration risk, such as supply chain disruptions. Strategic focus should include diversifying sources to mitigate dependency. Trade policy changes, like those noted in [BURS tariff notes], could impact costs and availability, urging importers to monitor regulatory shifts closely.

Table: Botswana Vaccines (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Vaccines Supplier lists

Action Plan for Vaccines Market Operation and Expansion

• Use hs code 3002 trade data to identify and onboard alternative suppliers from high-value clusters like the UK and Germany, reducing over-reliance on South Africa and strengthening Botswana's Vaccines supply chain resilience against disruptions.
• Monitor BURS tariff updates and trade policy changes monthly, using shipment frequency data to anticipate cost impacts and adjust sourcing strategies for Botswana Vaccines Import, avoiding unexpected expenses.
• Focus import strategy on high-margin human medical products within hs code 3002 trade data, targeting items with unit prices above USD 100, to capture premium pricing and increase profitability in Botswana's Vaccines Import market.
• Develop a dual sourcing model combining high-frequency, low-value suppliers for routine needs and high-value partners for specialized products, optimizing both cost and reliability in the Vaccines supply chain for Botswana.
• Analyze buyer-supplier transaction patterns to forecast demand cycles and align inventory with shipment frequencies, preventing stockouts or overstock situations and ensuring efficient Vaccines supply chain operations.

Take Action Now —— Explore Botswana Vaccines Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Vaccines Import 2025 May?

The sharp rise in unit prices (up to $143.34/kg) and volatile import volumes reflect market disruption, likely due to the U.S. imposing a 37% additional duty on imports from Botswana in April 2025, which constrained supply channels.

Q2. Who are the main origin countries of Botswana Vaccines (HS Code 3002) 2025 May?

The UK dominated by value (51.99%), while South Africa led in quantity (77.20%) and shipment frequency (41.72%), with Switzerland and Germany also notable for high-value shares.

Q3. Why does the unit price differ across origin countries of Botswana Vaccines Import?

Price gaps stem from product specialization: the UK supplies high-grade human medical products (e.g., immunological preparations at $117–244/unit), while South Africa focuses on lower-cost veterinary vaccines ($17.08/unit).

Q4. What should importers in Botswana focus on when buying Vaccines?

Prioritize diversifying suppliers to mitigate reliance on South Africa for bulk shipments and secure high-value products from the UK/Switzerland, while monitoring tariff risks.

Q5. What does this Botswana Vaccines import pattern mean for overseas suppliers?

High-value suppliers (UK/Germany) have pricing power for specialized products, while volume-focused suppliers (South Africa) face competition but benefit from consistent demand for cost-effective options.

Q6. How is Vaccines typically used in this trade flow?

Imports are segmented into veterinary preparations (high-volume, lower-cost) and human medical products (high-value, specialized), tailored for animal or public health applications.